BIIB vs VENU · P/E 21, rev $9.89B vs rev $17.9M
Biogen Inc (BIIB) versus Venu Holding Corporation (VENU) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
Venu Holding Corporation (VENU) is a restaurants company listed on AMEX.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported VENU revenue for 2025-12-31 was $17.9M. Net income was -$44.1M. Revenue was up 0.4% from 2024-12-31 to 2025-12-31. VENU currently screens at market cap $156.8M.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. VENU currently screens at market cap $156.8M.
Not investment advice. Open the BIIB and VENU stock pages for the full models.
Not investment advice.